Exploring Hematological Parameters and Their Prognostic Value in Adult COVID-19 Patients: Insights from Mogadishu, Somalia

Tere were no data on SARS-CoV-2 and hematology in Mogadishu, Somalia, despite the fact that many prior investigations of
SARS-CoV-2 and hematology have already been conducted in many diferent parts of the world. As a result, this study aimed to
assess hematological changes in COVID-19-infected patients at some selected hospitals in Mogadishu, Somalia. Methods.
Outright, 433 COVID-19 patients were included in this study, which used a hospital-based cross-sectional design to investigate
hematological alterations using the Mindray full automated hematological analyzer. Furthermore, ethical considerations were
taken into account during the study. All individuals provided informed consent prior to participation in the study. Data were
analyzed using SPSS. Results. Te median age of the current study was 54.65 ± 20.486 years. People with diabetes, high blood
pressure, asthma, or heart disease made up 21.2%, 21.2%, 20%, and 2.1% of the study population, respectively. According to the
patients’ hematological profles, 89.5% of them had leukopenia, 86.8% had lymphopenia, and 89% had neutrophilia. Monocytes,
eosinophils, basophils, and thrombocytes were typically normal although around 50.4% individuals exhibited anemia. Conclusion.
Hematological indicators can predict how bad the illness is and how it will turn out, which helps guide clinical therapy.
Leukopenia, neutrophilia, lymphopenia, and anemia were found in this study. At the time of admission, a thorough review of
laboratory parameters can help clinicians make a treatment plan and quickly give intensive care to the patients who need it most